Insider trades › Amgen › Matthew C. Busch
Matthew C. Busch: Amgen stock transactions
Matthew C. Busch (VP, Finance & CAO at Amgen) reported 1 transaction in AMGN stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Busch Matthew C..
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-08-07most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 7, 2026 | Grant or award | 730 | — | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.